tip

tip

TIP A COLLEAGUE

Key publications

Efficacy within anxiety disorders

Escitalopram and paroxetine in the treatment of generalised anxiety disorder

Baldwin et al., Br J Psych 2006 Sep; 189, 264-272

Escitalopram versus Paroxetine for social anxiety disorder: An analysis of efficacy for different symptom dimensions

Stein et al., Eur Neuropsychopharmacol. 2006 Jan;16(1):33-8

A 24-week randomized, double-blind, placebo-controlled study of escitalopram for the prevention of generalized social anxiety disorder.

Montgomery et al., J Clin Psychiatry. 2005 Oct;66(10):1270-8.

Prevention of relapse in generalized anxiety disorder by escitalopram treatment

Allgulander, International Journal of Neuropsychopharmacology 2005; 9: 1-11

Treatment of generalized anxiety disorder with escitalopram: pooled results from double-blind, placebo-controlled trials

Goodman WK, Bose A, Wang Q, Journal of Affective Disorders 2005; 161-167

Escitalopram and Paroxetine Compared to Placebo in the Treatment of Generalised Anxiety Disorder (GAD)

Baldwin et al., Clinical Neuroscience Division, University of Southampton, UK; H.Lundbeck A/S, Copenhagen, Denmark; H.Lundbeck A/S, Lysaker, Norway.

Efficacy and Tolerability of Escitalopram in 12- and 24-week Treatment of Social Anxiety Disorder: Randomised, Double-blind, Placebo-controlled, Fixed-dose study

Lader et al., Depression and Anxiety 2004; 19: 241-248

Improvement of Quality of Life in Panic Disorder with Escitalopram, Citalopram, or Placebo

Bandelow et al. Pharmacopsychiatry 2007; 40: 152-156

A Double-Blind Comparison of Escitalopram and Paroxetine in the Long-Term Treatment of Generalized Anxiety Disorder

Davidson et al. J Clin Psychiatry 2005; 66: 1441-1446

Escitalopram prevents relapse of obsessive-compulsive disorder

Fineberg et al. Eur Neuropsychopharmacol. 2007 May-Jun;17(6-7): 430-9.

Escitalopram in the treatment of panic disorder: a randomized, double-blind, placebo-controlled trial.

Stahl et al., J Clin Psychiatry. 2003 Nov;64(11):1322-7.

Escitalopram in obsessive-compulsive disorder: a randomized, placebo-controlled, paroxetine-referenced, fixed-dose, 24-week study.

Stein et al. Curr Med Res Opin. 2007 Apr;23(4):701-11.

Published: 23/05/2006 Last updated: 27/07/2010

www.irecover.com www.mypdinfo.com www.ebixa.com www.azilect.com www.serdolect.com www.depnet.com Disclaimer

H. Lundbeck A/S - Ottiliavej 9 - DK-2500 Copenhagen Valby - Phone +45 3630 1311 - Contact us